1832 Asset Management L.P. Exact Sciences Corp Transaction History

1832 Asset Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$47.19 - $70.77 $6.15 Million - $9.22 Million	130,300 New	130,300 $8.84 Million
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $98.6 Million - $131 Million	-846,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $84.3 Million - $120 Million	846,000 New	846,000 $113 Million
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $82.1 Million - $105 Million	-1,056,600 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $35.7 Million - $48.4 Million	395,100 Added 59.73%	1,056,600 $96 Million
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $7.83 Million - $10.3 Million	87,500 Added 15.24%	661,500 $74.4 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $35.6 Million - $55.4 Million	574,000 New	574,000 $47.6 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.